J
Jean-Pierre Van Buyten
Publications - 51
Citations - 2638
Jean-Pierre Van Buyten is an academic researcher. The author has contributed to research in topics: Neurostimulation & Chronic pain. The author has an hindex of 22, co-authored 44 publications receiving 2279 citations.
Papers
More filters
Journal ArticleDOI
Spinal cord stimulation for chronic back and leg pain and failed back surgery syndrome: a systematic review and analysis of prognostic factors.
TL;DR: Despite an increase in the number of studies over the last 10 years, the level of evidence for the efficacy and safety of spinal cord stimulation in patients with chronic back and leg pain/failed back surgery syndrome remains “moderate.”
Journal ArticleDOI
Sustained Effectiveness of 10 kHz High-Frequency Spinal Cord Stimulation for Patients with Chronic, Low Back Pain: 24-Month Results of a Prospective Multicenter Study
TL;DR: In patients with chronic low back pain, HF10 SCS resulted in clinically significant and sustained back and leg pain relief, functional and sleep improvements, opioid use reduction, and high patient satisfaction.
Journal ArticleDOI
High‐Frequency Spinal Cord Stimulation for the Treatment of Chronic Back Pain Patients: Results of a Prospective Multicenter European Clinical Study
TL;DR: The objective of this prospective, open‐label, multicenter European clinical trial was to quantify the efficacy and safety of a spinal cord stimulation system that utilizes high‐frequency waveforms, which do not produce paresthesia, for the treatment of chronic, intractable pain of the back and/or limbs.
Journal ArticleDOI
Spinal cord stimulation for complex regional pain syndrome: A systematic review of the clinical and cost‐effectiveness literature and assessment of prognostic factors
TL;DR: The clinical and cost‐effectiveness of spinal cord stimulation in the management of patients with complex regional pain syndrome (CRPS) and the potential predictors of SCS outcome are reviewed.
Journal ArticleDOI
The cost effectiveness of spinal cord stimulation in the treatment of pain: a systematic review of the literature
Rod S Taylor,Rebecca J. Taylor,Jean-Pierre Van Buyten,Eric Buchser,Richard B. North,Susan Bayliss +5 more
TL;DR: It is found that across a range of medical indications, the initial healthcare acquisition costs of SCS implantation are consistently offset by a reduction in post-implant healthcare resource demand and costs.